Novel Purification Process for Amyloid Beta Peptide(1-40)

Amyloid beta peptide (Aβ)-related studies require an adequate supply of purified Aβ peptide. However, Aβ peptides are “difficult sequences” to synthesize chemically, and low yields are common due to aggregation during purification. Here, we demonstrate an easier synthesis, deprotection, reduction, cleavage, and purification process for Aβ(1-40) using standard 9-fluorenylmethyloxycarbonyl (Fmoc)-protected amino acids and solid-phase peptide synthesis (SPPS) resin [HMBA (4-hydroxymethyl benzamide) resin] that provides higher yields of Aβ(1-40) than previous standard protocols. Furthermore, purification requires a similar amount of time as conventional purification processes, although the peptide must be cleaved from the resin immediately prior to purification. The method described herein is not limited to the production of Aβ(1-40), and can be used to synthesize other easily-oxidized and aggregating sequences. Our proposed methodology will contribute to various fields using “difficult sequence” peptides, such as pharmaceutical and materials science, as well as research for the diagnosis and treatment of protein/peptide misfolding diseases.

[1]  M. Brimble,et al.  Efficient synthesis and characterisation of the amyloid beta peptide, Aβ1-42, using a double linker system. , 2018, Organic & biomolecular chemistry.

[2]  E. Kobatake,et al.  Fluorescent and luminescent fusion proteins for analyses of amyloid beta peptide aggregation , 2017, Journal of peptide science : an official publication of the European Peptide Society.

[3]  M. Meldal,et al.  C-Terminally modified peptides via cleavage of the HMBA linker by O-, N- or S-nucleophiles. , 2016, Organic & biomolecular chemistry.

[4]  Tuomas P. J. Knowles,et al.  The amyloid state and its association with protein misfolding diseases , 2014, Nature Reviews Molecular Cell Biology.

[5]  I. Hamley The amyloid beta peptide: a chemist's perspective. Role in Alzheimer's and fibrillization. , 2012, Chemical reviews.

[6]  M. Biancalana,et al.  Molecular mechanism of Thioflavin-T binding to amyloid fibrils. , 2010, Biochimica et biophysica acta.

[7]  J. Kelly,et al.  Site-specific modification of Alzheimer's peptides by cholesterol oxidation products enhances aggregation energetics and neurotoxicity , 2009, Proceedings of the National Academy of Sciences.

[8]  B. Penke,et al.  Synthesis of Aβ[1‐42] and its derivatives with improved efficiency , 2007, Journal of peptide science : an official publication of the European Peptide Society.

[9]  R. Tanzi,et al.  Twenty Years of the Alzheimer’s Disease Amyloid Hypothesis: A Genetic Perspective , 2005, Cell.

[10]  Y. Kiso,et al.  Novel and efficient synthesis of difficult sequence-containing peptides through O-N intramolecular acyl migration reaction of O-acyl isopeptides. , 2004, Chemical communications.

[11]  A. Clippingdale,et al.  Amyloid-β as a “Difficult Sequence” in Solid Phase Peptide Synthesis , 2004 .

[12]  Y. Kiso,et al.  Design and synthesis of a novel water-soluble Aβ1-42 isopeptide: an efficient strategy for the preparation of Alzheimer's disease-related peptide, Aβ1-42, via O–N intramolecular acyl migration reaction , 2004 .

[13]  M. Skwarczynski,et al.  ON intramolecular acyl migration reaction in the development of prodrugs and the synthesis of difficult sequence‐containing bioactive peptides , 2004, Biopolymers.

[14]  A. Clippingdale,et al.  Amyloid-beta as a "difficult sequence" in solid phase peptide synthesis. , 2004, Protein and peptide letters.

[15]  M. Mutter,et al.  Pseudo-prolines (ΨPro): direct insertion of ΨPro systems into cysteine containing peptides , 2002 .

[16]  D. Walsh,et al.  An improved method of preparing the amyloid β-protein for fibrillogenesis and neurotoxicity experiments , 2000, Neurobiology of Aging.

[17]  W. Chan,et al.  Fmoc solid phase peptide synthesis : a practical approach , 2000 .

[18]  E. Giralt,et al.  Reduction of methionine sulfoxide with NH4I TFA: Compatibility with peptides containing cysteine and aromatic amino acids , 1998 .

[19]  Bruce A. Yankner,et al.  Aging renders the brain vulnerable to amyloid β-protein neurotoxicity , 1998, Nature Medicine.

[20]  J. Kelly,et al.  Alternative conformations of amyloidogenic proteins govern their behavior. , 1996, Current opinion in structural biology.

[21]  W. Turnell,et al.  Improved preparation of β-amyloid(1–43): structural insight leading to optimised positioning of N-(2-hydroxy-4-methoxybenzyl)(Hmb) backbone amide protection , 1995 .

[22]  R. Sheppard,et al.  N,O‐bisFmoc derivatives of N‐(2‐hydroxy‐4‐methoxybenzyl)‐amino acids: Useful intermediates in peptide synthesis , 1995, Journal of peptide science : an official publication of the European Peptide Society.

[23]  G. Glenner Alzheimer's disease: Its proteins and genes , 1988, Cell.